NovaBay Pharmaceuticals, Inc.
Reinvesting dividends added $113,303.57 extra to your NovaBay Pharmaceuticals, Inc. investment over this period.
| Ex-Date | Dividend | Reinvest Price | Shares Added |
|---|---|---|---|
| 2025-09-30 | $0.80 | $1.28 | +0.625000 |
NovaBay Pharmaceuticals, Inc. (NBY) is a dividend-paying stock. Over the past year, the company paid 1 dividend totaling $0.8000 per share. When these dividends are reinvested through a DRIP (Dividend Reinvestment Plan), they purchase additional shares, which then generate their own dividends—creating a compounding effect that can significantly boost long-term returns.
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform. The calculation accounts for the compounding effect where reinvested dividends generate their own future dividends.
NovaBay Pharmaceuticals, Inc. (NBY) delivered a total return of 2845.89% over the past year when dividends are reinvested. The price-only return was 1712.86%, meaning dividends contributed an additional 1133.04 percentage points to total returns.
A $10,000 investment in NovaBay Pharmaceuticals, Inc. one year ago would be worth $294,589 today with dividends reinvested (DRIP). Without reinvesting dividends, the same investment would be worth $181,286. Dividend reinvestment added $113,304 to the portfolio value.
Yes, NovaBay Pharmaceuticals, Inc. (NBY) pays dividends. Over the past year, NBY paid 1 dividend totaling $0.8000 per share. Reinvesting these dividends through a DRIP can significantly boost long-term returns.
Screen for dividend stocks with the highest total returns (including DRIP). See which dividend stocks actually grow your wealth.
Calculate total returns for related stocks: